David E. Goel, 10% Owner of Aura Biosciences AURA, has filed 2 purchases and 2 sales on the open market. Over the past 12 months that comes to a net sale of $49M. The latest trade was on 05/07.

DG

DG

David E. Goel

10% Owner

Company

Aura Biosciences AURA

First filing

23/06/20

Trades

14 trades

Buys / sales

2 / 2

12-month net buying

−$49M

Last trade

05/07

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Aura BiosciencesAURA	Open-market sale	05/07	05/11	6,922,870 sh	$5.64	$39,044,986.8	−100.0%
Zentalis PharmaceuticalsZNTL	Open-market sale	25/12/15	25/12/15	7,500,000 sh	$1.33	$9,975,000	−53.7%
Aura BiosciencesAURA	Open-market buy	23/11/09	23/11/09	1,560,000 sh	$9.00	$14,040,000	+29.1%
Zentalis PharmaceuticalsZNTL	Open-market buy	23/06/20	23/06/20	4,760,000 sh	$22.66	$107,861,600	+51.7%